6/12/2023 0 Comments Bad blood john carreyrou![]() ![]() By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. ![]() Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. ![]() When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. There was just one problem: The technology didn't work.įor years, Holmes had been misleading investors, FDA officials, and her own employees. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. ![]()
0 Comments
Leave a Reply. |